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Endothelial Rictor is crucial for 
midgestational development and 
sustained and extensive FGF2-
induced neovascularization in the 
adult
Fabio Aimi1,*, Stavroula Georgiopoulou1,*, Ina Kalus1, Fabienne Lehner1, Alica Hegglin2, 
Përparim Limani4, Vinicius Gomes de Lima1, Markus A. Rüegg3, Michael N. Hall3, 
Nicole Lindenblatt2,5, Elvira Haas1, Edouard J. Battegay1,5,6 & Rok Humar1,5
To explore the general requirement of endothelial mTORC2 during embryonic and adolescent 
development, we knocked out the essential mTORC2 component Rictor in the mouse endothelium 
in the embryo, during adolescence and in endothelial cells in vitro. During embryonic development, 
Rictor knockout resulted in growth retardation and lethality around embryonic day 12. We detected 
reduced peripheral vascularization and delayed ossification of developing fingers, toes and vertebrae 
during this confined midgestational period. Rictor knockout did not affect viability, weight gain, 
and vascular development during further adolescence. However during this period, Rictor knockout 
prevented skin capillaries to gain larger and heterogeneously sized diameters and remodeling into 
tortuous vessels in response to FGF2. Rictor knockout strongly reduced extensive FGF2-induced 
neovascularization and prevented hemorrhage in FGF2-loaded matrigel plugs. Rictor knockout also 
disabled the formation of capillary-like networks by FGF2-stimulated mouse aortic endothelial cells 
in vitro. Low RICTOR expression was detected in quiescent, confluent mouse aortic endothelial 
cells, whereas high doses of FGF2 induced high RICTOR expression that was associated with strong 
mTORC2-specific protein kinase Cα and AKT phosphorylation. We demonstrate that the endothelial 
FGF-RICTOR axis is not required during endothelial quiescence, but crucial for midgestational 
development and sustained and extensive neovascularization in the adult.
Controlled angiogenesis is required during early development to generate the peripheral vasculature and 
in the adult to regenerate damaged tissue and the endometrial lining. In contrast, uncontrolled angio-
genesis, which is characterized by an unorganized, tortuous and hyper-permeable vascular network, is 
induced in many pathological processes, including tumor growth, metastasis, diabetic retinopathy, and 
arthritis1,2. Angiogenic cascades are initiated by potent angiogenic molecules, such as fibroblast growth 
factor (FGF) or vascular endothelial growth factor (VEGF). FGF and VEGF both activate the protein 
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kinase mammalian target of rapamycin (mTOR)3,4 via phosphatidylinositide 3-kinase (PI3K) activation. 
Pharmacological inhibition of mTOR-linked signaling has been shown to reduce tumor angiogenesis 
and tumor growth in various experimental models. The mTOR inhibitor, rapamycin, suppresses tumor 
angiogenesis in vivo by downregulating VEGF5,6. Furthermore, dual PI3K and mTOR inhibitors block 
VEGF-induced neovascularization in mice7–9. Similarly, dual mTOR inhibitors have been shown to con-
siderably reduce angiogenesis and regrowth compared to rapamycin alone10.
Mammalian TOR acts as the core protein kinase in two different multi-protein complexes: mTOR 
complex (mTORC) 1 and 2. In most tissues, rapamycin is largely selective for mTORC111.
The complex of interest in this study is mTORC2, which contains the essential regulatory proteins 
RICTOR, mSIN1, and mLST8. mTORC2 integrates signals from growth factors to regulate cell sur-
vival or cytoskeleton organization. In addition, mTORC2 phosphorylates AGC kinase family members, 
such as AKT and protein kinase Cα (PKCα )11 and is implicated in the epithelial-mesenchymal tran-
sition (EMT)12,13. Embryos lacking Rictor or Mlst8 in the whole body are growth retarded and die at 
around midgestation14,15. We have previously shown that hypoxia, a main stimulus for angiogenesis, 
induces transient mTORC1 activity, whereas mTORC2-induced AKT activation is sustained and critical 
for endothelial proliferation16. This suggested a specific function of mTORC2 in angiogenesis in vivo. 
Recently, distinct mTORC2 signaling pathways have been reported to regulate endothelial cell prolifera-
tion and vascular assembly in response to VEGF17.
High doses of rapamycin or its prolonged delivery can also block mTORC2 in endothelial cells18. 
Thus, rapamycin-based inhibitors cannot differentiate between the functions of mTORC1 and mTORC2 
and specific mTORC2 inhibitors are not available. Here we therefore deleted Rictor in the endothelium to 
study the general requirement of endothelial mTORC2 during embryonic and adolescent development. 
Our second main aim was to elucidate whether endothelial RICTOR participates in vascular changes 
upon wounding and extensive angiogenic stimulation in the existing capillary bed and during de novo 
angiogenesis.
Results
Loss of endothelial homozygous Rictor results in embryonic lethality around embryonic day 
(E) 11.5–12.5. Whole-body mTORC2 knockout mice are embryonically lethal. Guertin and col-
leagues suggested vascular defects as a potential reason for early embryonic death14,15. We further inves-
tigated the loss of Rictor in endothelial cells during embryogenesis by using a constitutive VE-Cadherin 
promoter-driven Cre and LacZ reporter containing19 Rictor knockout. The analysis of 101 pups revealed 
two homozygous Rictor knockout mice, indicating predominant embryonic lethality. Heterozygous Rictor 
knockout and wildtype mice were born at expected Mendelian ratios (Fig. 1A). Interestingly, the two sur-
viving RictorΔec mice were females, fertile, and phenotypically normal. When further used for breeding, 
these two RictorΔec mice gave birth only to heterozygous and wildtype Rictor pups. We then analyzed 
43 embryos received after terminated pregnancy on day E10.5. 11 out of these embryos were genotyped 
as homozygous knockouts. LacZ reporter-positive RictorΔec and wildtype embryos displayed endothe-
lial cell-specific Cre recombination, as visualized by β -galactosidase staining in intersegmental vessels, 
intracranial arteries, and the dorsal aorta. RictorΔec homozygous embryos generally appeared normal 
and were viable at this time point. LacZ activity in the dorsal longitudinal anastomotic vessel was clearly 
visible in wildtype embryos but was less prominent in 7 out of 11 RictorΔec embryos, indicating reduced 
or delayed angiogenesis into the periphery from intersegmental vessels (Fig. 1B, for additional pictures 
see supplementary Fig. S1). We found only one noticeable distinct vascular feature in 2 out of 11 RictorΔec 
embryos compared to controls: Vascular remodeling around the vitelline artery that usually occurs at 
this or earlier timepoints20 was characterized by the presence of numerous, thin parallel anastomosing 
vessels which are not observed in wild type mouse embryos (arrows in supplementary Fig. S1, lower 
panels). Thus, erythropoiesis and vasculogenesis of the primitive vascular plexus with further remode-
ling of arteries and veins, which is completed on E10.521, was not modulated by endothelial mTORC2. 
To precisely determine the time point of lethality, overlapping tamoxifen-injection schemes in pregnant 
mice with homozygous loxed Rictor gene and inducible VE-Cadherin CreERT2 recombinase were used 
(Fig. 2A). Injecting tamoxifen three times in pregnant mice, starting at E7.5, produced marked and sig-
nificant reductions in litter size (Fig. 2B). However, injecting tamoxifen twice at E7.5 did not result in 
any differences in litter size (Fig. 2B). Rictor knockout by 60% is achieved with two injections of tamox-
ifen, whereas nearly homozygous (92%) knockout is achieved with three injections of tamoxifen every 
second day22. Thus, with three injections starting on E7.5, knockout of Rictor was likely to be maximal 
starting from E11.5–E12.5. On E17.5, one third of the embryos were growth retarded, and the remain-
ing embryos were absorbed (Fig.  2C). In addition, more than 90% of analyzed embryos were growth 
retarded after tamoxifen injections began on E6.5 and E8.5 (Fig. 2C). Interestingly, tamoxifen injections 
that began on E12.5 and E14.5 had no influence on viability and growth (Fig. 2C).
Embryos that were injected with tamoxifen on E8.5 had a body length of approximately 14 mm, 
whereas embryos that were injected on E14.5 had a body length of 19.5 mm. Wildtype embryos at embry-
onic day 17.5 displayed a body length of 18–22 mm (Fig. 2D). Furthermore, growth-retarded embryos 
did not display wrinkled skin; instead, the skin was rather thin, and subcutaneous veins were visible 
(Fig. 2E). To investigate whether endothelial-specific Rictor knockout causes a delay in vascularization, 
embryos received three injections of tamoxifen that started on E7.5, after which they were sacrificed 
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at E12.5. The majority of endomucin-stained vascular plexi were present in both RictoriΔec and control 
embryos. Due to mortality at this time point, we detected only 5 knockout embryos out of three termi-
nated pregnancies with induced knockout. We detected reduced sprouting angiogenesis in subdermal 
vessels in the ventral region and of RictoriΔec embryos (2 out of 5 RictoriΔec embryos) (Fig. 2F). Also, the 
temporary hyaloid vessels in the eye had formed incompletely (3 out of 5 RictoriΔec embryos) (Fig. 2F). 
In growth-retarded RictoriΔec mice that were that were first injected with tamoxifen on E.6.5 and E8.5, 
ossification centers in the fingers were strongly reduced or missing when analyzed on E17.5 as compared 
to embryos that were first injected on E14.5 (Fig.  2G, alizarin red (bone) and alcian blue (cartilage) 
stainings and quantification of ossification centers below). Embryos that were first injected on E14.5 
displayed an ossification progress comparable to wildtype mice as demonstrated earlier by Gollner et 
al.23 Similarly, the progress of ossification in the vertebrae was clearly delayed in embryos that were first 
injected with tamoxifen on E8.5, and the long bones of the upper and lower limbs were significantly 
shorter in embryos that received their first tamoxifen injections on E6.5 and E8.5 compared to embryos 
that received their first tamoxifen injections on E14.5 (supplementary Fig. S2). CD31 staining from skin, 
brain, skeletal muscle, lung, and colon sections of growth-retarded RictoriΔec mice on the other hand 
were morphologically indistinguishable from sections of wildtype control mice (supplementary Fig. S3).
Figure 1. Constitutive homozygous endothelial Rictor knockout during embryonic development 
is generally lethal. (A) Rictorflox/flox females were mated with Rictorflox/−; VE-Cadherin-Cre+/−; LacZ 
reporter+/+ males to generate homozygous deletion of Rictor in the endothelium. Litter genotypes were 
determined by qPCR and are displayed as total distribution and average number of pups per genotype 
(ntotal pups = 101, ****P < 0.0001, ***P < 0.001, 1-way ANOVA with Bonferroni multiple comparison) (B). 
The abovementioned breeding scheme was used to isolate embryonic day (E) 10.5 wildtype and endothelial 
Rictor knockout embryos. Representative β -galactosidase staining (blue) of E10.5 embryos shows the active 
sites of VE-Cadherin-Cre recombination. Arrows on the right indicate reduced peripheral LacZ staining in 
Rictor knockout embryos (n = 7 of 11).
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Figure 2. Lethality and growth retardation of induced endothelial Rictor knockout mice peaks around 
E12. (A) Tamoxifen (Tx) injection scheme: Three doses of Tx were administered to pregnant females every 48 
hours, beginning on E6.5, E7.5, E8.5, E10.5, E12.5, and E14.5. Pregnant females were sacrificed, and embryos 
were harvested on E17.5 for further histological analysis. Grey area symbolically depicts stepwise Rictor knockout. 
Control females were injected with corn oil. (B) RictoriΔec mice exhibit decreased litter size. Statistical analysis of 
the litter size of individual breedings (nEday) after three and two Tx injections at different time points (nE6.5 = 3, 
nE7.5 = 3, nE8.5 = 4, nE10.5 = 3, nE12.4 = 4, nE14.5 = 4,) compared to controls (n = 7). *P < 0.05, Student’s t-test.  
(C) Statistical analysis of normal, growth retarded, and absorbed embryos per breeding after Tx-injection at 
different time points. Total litter size for breeding at each time point was set to 100%, nbreedings = 3. (D) Statistical 
analysis of the length of surviving embryos per litter at different starting time points of Tx injections. n = 4 
(embryos per time point, length was measured in both extremities), *P < 0.01 compared to controls. Student’s 
t-test. (E) Representative picture of a E17.5 RictoriΔec embryo that was induced by Tx on E8.5 in comparison to a 
wildtype embryo. (F) RictoriΔec embryos displayed distinct vascular deficits in the eye when Tx injections started on 
E7.5 and embryos harvested at E12.5 and stained with the vessel-specific antibody, endomucin. Scale bar = 100 μ m. 
Arrows indicate angiogenic sprouts. (G) RictoriΔec embryos display a delay in ossification. Representative pictures of 
the upper limbs of embryos stained with alizarin red (bone) and alcian blue (cartilage). Arrows: ossification centers. 
Below, quantification with number of ossification centers in fingers upon knockout of Rictor at indicated starting 
time points of Tx injections. *P < 0.05, **P < 0.01, compared to E14.5; nembryo = 4 (number of centers was measured 
in both extremities and averaged for each embryo), Mann-Whitney Rank Sum Test.
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In summary, endothelial Rictor knockout resulted in lethality which peaked around E12 and growth 
retardation close to this time point in midgestation. Growth retardation was accompanied by delayed 
bone ossification in fingers, toes and vertebrae. Rictor knockout delayed peripheral angiogenesis, but did 
not generally affect vascular plexus formation.
Endothelial-specific Rictor knockout has no obvious effect on viability and weight gain dur-
ing adolescence into adulthood. We proceeded to analyze the general requirement of endothelial 
mTORC2/RICTOR using the inducible VE-Cadherin-driven CreERT2 variant (RictoriΔec) during adoles-
cence from the age of 4 weeks (at the time of tamoxifen-induced Rictor knockout) to adulthood, up to 
an age of 28 weeks. No statistically significant differences in weight gain were observed between geno-
types and genders (Fig. 3A). Furthermore, all groups displayed normal health and viability. At the end 
of the weight study, the aorta from male control and RictoriΔec mice were removed, the endothelium was 
scraped, and Rictor mRNA levels were determined by quantitative polymerase chain reaction (qPCR) to 
show stable, efficient, and significant knockdown of Rictor (Fig. 3B). Adolescent double transgenic mice 
(Cre+/+; Rictorlox/lox) also displayed specific CRE expression in capillaries from the mouse dermal skin 
muscle, as shown by estrogen receptor-specific staining in tissues that were used for intravital experi-
ments (Fig.  3C). Although VE-Cadherin promoter-driven Cre recombination may also affect hemato-
poietic development22, we found similar hematological profiles in 8-week-old control and RictoriΔec mice. 
These profiles were comparable to those of healthy C57/Bl6 mice (supplemental Fig. S4).
These experiments demonstrate that the stable ablation of endothelial mTORC2 in adolescent mice, 
which persisted until late adulthood, did not cause obvious general health problems, as supported by 
normal hematological profiles, weight gain, and viability.
Figure 3. Rictor knockout does not affect weight gain and viability in adolescent mice. (A) Body weights 
were followed in male and female mice over a period of 27 weeks after induction of knockout or control 
on week 4. n = 10 per genotype and gender, n.s., 2-way ANOVA with group-wise comparison. All mice 
displayed normal health, behavior, and viability. (B) At the end of the experiment, RNA was extracted from 
endothelial layer for quantitative polymerase chain reaction (PCR) analysis to test for efficient excision 
of Rictor (n = 3/2, *P < 0.05. 2-tailed T-test), and qualitatively for purity of endothelial tissue (endothelial 
marker Pecam1, smooth muscle marker α SMA). Total aorta mRNA was used as comparative control. 
Representative immunostainings for estrogen receptor 2 (red fluorescence) in histological sections of 
the skinfold from 10-week-old RictoriΔec mice demonstrates specific expression of CreERT2 recombinase 
associated with capillaries.
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Rictor knockout in mouse aortic endothelial cells (MAEC) differentially disables the formation 
of capillary-like endothelial networks. Our results so far suggested, that knockout of Rictor in 
endothelial cells has no obvious effects on the development during adolescence in mice and therefore 
may not affect basic physiologic parameters of the endothelial cell such as survival and homeostatic 
functions in the existing and developing vasculature. Before continuing investigations about the role 
of mTORC2 in activated endothelium in vivo, we used an in vitro assay to determine the angiogenic 
response of control and Rictor knockout mouse aortic endothelial cells to the two major angiogenic mol-
ecules FGF and VEGF (Characteristic endothelial markers of these cells are shown in supplementary Fig. 
S5). After plating on a basement membrane matrix gel, endothelial cells build capillary-like tubes with a 
lumen within a short time. Cells initially attach to the matrix and then migrate towards each other, after 
which they align and form tubes24. We found that control MAEC formed connected master segments in 
the presence of the diluent (1% fetal calf serum [FCS]), FGF2, and VEGFA (Fig. 4A). Rictor knockout 
was induced by CRE recombinase expression after adenoviral transfection (Fig.  4, lower left panel). 
We found, that the ability of MAEC with Rictor knockout (Rictor ko MAEC) to build stable contacts 
and connecting tubes was substantially disabled: Knockout of Rictor prevented MAEC from forming 
capillary-like tubes in unstimulated conditions. Upon FGF2 stimulation, Rictor ko MAEC arranged into 
star-like shapes, with sprouts extending from cell clusters, but did not establish contacts to other cell 
clusters and formed significantly less master segments compared to control (Fig.  4). In contrast to the 
study by Wang et al.17, VEGFA stimulation partially rescued endothelial network formation in Rictor ko 
Figure 4. Rictor knockout in mouse aortic endothelial cells (MAEC) decreases endothelial network 
formation. (A) Representative micrographs show endothelial network formation after 18 hours of seeding. 
Quantification (total number of master segments that connect to at least two other segments) of endothelial 
tube formation from three experiments is shown below. (Bars; mean and SEM, nexp = 3, *P < 0.05 versus 
control. Paired T-Test). FGF-treated Rictor ko MAEC typically formed star-shaped centers with omni-
directional sprouting and no connection to neighboring centers. Efficient Rictor knockout displayed by 
RICTOR and CRE protein expression from control (AdCre–) and Rictor ko (AdCre+) MAEC (n = 3) is 
displayed on the lower right.
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MAEC. Rictor ko MAEC were able to form some substantial networks and organized tubes, albeit in in 
numbers that were small and similar to those of control MAEC (Fig. 4).
As we found that the angiogenic response to FGF2 was significantly more affected by Rictor knockout 
than that to VEGF, we further focused on FGF2-mediated responses in endothelial cells and angiogenesis 
assays in vivo in this study.
FGF2 amplifies RICTOR protein and RICTOR-dependent phosphorylation of AKT on serine 
473 and PKCa on serine 657. Interestingly, we found a consistently low expression of RICTOR in 
starved, unstimulated and confluent MAEC isolates, whereas FGF2 amplified RICTOR protein levels. 
Quantification demonstrated a significant increase in RICTOR protein at 5 ng/ml of FGF2 peaking at an 
8-fold expression compared to diluent at 50 ng/ml of FGF2. (Fig. 5A, upper left panels). We assessed how 
FGF2-induced signaling is altered in mTORC2-deficient endothelial cells and focused on one of the main 
mTORC2 downstream targets, PKCα and AKT25. In control MAEC, FGF2 induced the dose-dependent 
phosphorylation of the hydrophobic motif (HM) of PKCα on serine 657 (PSer657PKCα ). Interestingly, 
deletion of Rictor strongly decreased PKCα protein levels and accordingly blunted the phosphorylation 
of the HM of PKCα in response to FGF2, FCS, and insulin (Fig.  5A). PKCα signaling was strongly 
disabled in Rictor ko MAEC, and this was most likely a result of total PKCα protein destabilization 
and degradation due to absent phosphorylation25. We then assessed the impact of Rictor deletion in 
MAEC on mTORC downstream target protein kinase AKT (also known as PKB). The phosphorylation 
of the activation loop (A-loop) on threonine 308 (PThr308AKT) by phosphoinositide-dependent kinase 1 
(PDK1) and of the HM at serine 473 of AKT (PSer473AKT) by mTORC2 results in AKT activation11,26. 
In control MAEC, FGF2 induced a marked and dose-dependent PSer473AKT that peaked at 25 ng/ml 
of FGF2. Rictor knockout efficiently and significantly blunted FGF2-, FCS-, and insulin-induced AKT 
phosphorylation (Fig.  5A, quantification to the right). The disruption of mTORC2 has been shown to 
decrease PThr308AKT in some cancer cell lines11. In control MAEC, PThr308AKT was robustly induced by 
FGF2, FCS, and insulin. After Rictor knockout, we did not detect a significant reduction in PThr308AKT 
(Fig. 5A). These results are consistent with reports in cells or tissues that were derived from mice with 
genetic deletions of mTORC2 components. In these mice, A-loop phosphorylation was not disrupted in 
the absence of PSer473AKT14,25,27.
The depletion of AKT phosphorylation by Rictor knockout may influence mTORC1 signaling. AKT 
phosphorylates and inhibits tuberous sclerosis 2 (also known as tuberin), thus resulting in the activation 
of mTORC1- p70S6 kinase1 (S6K1)28. We found that FGF2 dose-dependently promoted S6K1 phospho-
rylation in control MAEC. After Rictor knockout, a minor but insignificant reduction in FGF2-induced 
S6K1 phosphorylation was detected (Fig.  5A). No differences in the phosphorylation of extracellular 
signal-regulated kinase 1 and 2 (ERK1/2) by the FGF2 gradient were observed in control MAEC and 
Rictor ko MAEC (Fig. 5A)29.
A close cross-talk exists among FGF2 and the different members of the VEGF family during angio-
genesis and several studies have suggested that FGF2 induces neovascularization indirectly by activation 
of the VEGF/VEGFR system30. We confirmed that Vegfa mRNA substantially increased after FGF2 stim-
ulation, yet Rictor knockout did not affect this induction. To investigate whether endothelial mTORC2 
might modulate in vitro angiogenesis in response to FGF2 by regulation of VEGF receptors, we measured 
the mRNA-levels of the two main VEGF-receptors Flt1 (VEGFR1), which is characteristic for stalk cells 
and quiescent endothelium, and Kdr (VEGFR2), upregulated in tip cells31. Interestingly we found a strong 
FGF2-induced upregulation of the membrane form of Flt1 (mFlt1) and an even stronger induction of sol-
uble Flt1 receptor (sFlt1) mRNA (Fig. 5B). Kdr message was present and decreased after FGF-stimulation 
(Fig. 5B). However, Rictor knockout cells induced mFlt1 and sFlt1 and reduced Kdr message congruent 
to control cells after FGF2 stimulation, which argues against endothelial tip-/stalk-cell modulation by 
mTORC2. FGF2 also stimulates VEGFA in endothelial cells of forming capillaries and cultured aortic 
endothelial cells32. Similarly, FGF receptor 1 (Fgfr1) message equally increased in control and Rictor ko 
MAEC. The decrease in PKCα protein after Rictor knockout was due to posttranscriptional mechanisms 
as PKCα gene expression was equal in control and Rictor ko MAEC (Fig. 5B).
Furthermore, we did not observe any significant differences in endothelial proliferation over a period 
of 72 hours in the dose response to FGF2 (Fig.  5C) or FGF2-induced-migration in a wound assay 
(Fig. 5D). However, a weak but significant (P < 0.05, Nexp = 4) reduction in proliferation was detected in 
the presence of FCS (Fig. 5C). Similarly, we found a significant reduction in VEGFA-induced prolifera-
tion by Rictor knockout (Supplemental Fig. S6).
In conclusion, FGF2 amplified RICTOR protein in control MAEC and Rictor deletion in FGF2- 
stimulated MAEC strongly blunted PKCα signaling and reduced AKT activity by depleting Ser473 phos-
phorylation. Rictor deletion had no effects on mTORC1 signaling and FGF-induced proliferation, migra-
tion nor did it interfere with FGF2-induced modulation of Flt1, Kdr and Vegfa expression levels.
The structure of the capillary bed of the striated skin muscle is not altered by endothelial- 
specific Rictor knockout. In preparation to study mTORC2-dependent vascular changes in response 
to wounding and FGF2 in vivo, we first recorded the capillary morphology in the existing striated skin 
muscle (Panniculus carnosus) vascular bed as baseline. To do so we surgically mounted a dorsal skinfold 
chamber33,34 to 8-week-old control and RictoriΔec mice. We observed that the baseline capillary bed, which 
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Figure 5. FGF2 amplifies RICTOR protein and Rictor-dependent phosphorylation of AKT on serine 473 
and PKCa on serine 657. (A) Western blots show RICTOR and downstream targets of mTORC2 after 15 min 
stimulation of control and Rictor ko MAEC with 5–50 ng/ml of FGF2, 10% FCS or 1 μ g/ml insulin (Ins). 
Significant increase in RICTOR protein at 5 ng/ml of FGF2 stimultion peaking at an 8-fold expression at 50 ng/ml 
of FGF2 compared to diluent in 3 repeated experiments in a MAEC isolate (control = white bars, nexp = 3, 
*P < 0.05, **P < 0.001, 1-way ANOVA with Bonferroni multiple comparison, upper left panels). PKCα protein 
was nearly absent in Rictor ko MAEC compared to control (middle panels). Densitometric quantification shows 
dose-dependent AKT Ser473 phosphorylation in response to FGF2, FCS and Ins (right panels, nexp = 3, *P < 0.05, 
**P < 0.01, ***P < 0.001, repeated measures ANOVA). Lower middle blots show S6K1 phosphorylation on PThr389 
compared to total S6K1 and phosphorylation of ERK1/2 on PThr202/Tyr204 compared to total ERK1/2 after Rictor 
knockout. (B) mRNA expression after 1–6 hours stimulation (25 ng/ml FGF2) of control and Rictor ko MAEC 
of VEGF receptor 1 (mFLT1, sFlt1), VEGF receptor 2 (Kdr), VEGFA (Vegfa), FGF receptor 1 (Fgfr1) and protein 
kinase Cα (PKCα) detected by quantitative real-time PCR (n = 3, ns knockout versus control, repeated measures 
ANOVA). (C) Absolute proliferation values (Absorption = A450 nm-A650 nm) in FGF2-stimulated control (open 
circles) or Rictor ko (filled squares) MAEC are presented. (nexp = 3, n.s., repeated measures ANOVA). In response 
to 10% FCS (right), proliferation of Rictor ko MAEC was significantly lower compared to that of control MAEC 
(n = 3, *P < 0.05, two-tailed T-test). (D) Migration of MAEC was measured after FGF2 (25 ng/ml) or diluent 
administration for 1, 3, 6 and 9 hours (wound completely closed = 1, n = 3, n.s., repeated measures ANOVA).
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was recorded 3 days post-chamber surgery, appeared very similar in 8-week-old control and RictoriΔec 
mice (Fig. 6A; supplementary video 1). Analysis of all capillary diameters measured at baseline did not 
reveal significant differences (Fig. 6A)). In both experimental groups, the vascular bed consisting of the 
panniculus carnosus with its capillary structures was organized in the typical parallel orientation, and the 
subcutaneous layer with draining arterioles and venules exhibited the typical perfusion pattern of the 
dorsal skinfold chamber capillaries, as observed in previous studies33. Thus, ablation of endothelial Rictor 
did not interfere with the development or directly observable functionality of the intact, unstimulated 
dermal microvasculature in adolescent mice, which is in line our observation of normal growth, viability 
and weight gain of adolescent mice lacking endothelial Rictor.
Wounding-induced capillary diameter remodeling is not impaired by endothelial-specific 
Rictor knockout. We then modified this chamber by additionally removing cutis and subcutis on 
the opposite side of the observation window. This defect was sealed by growth factor-reduced matrigel 
(suppl. Fig. S7). In the first set of experiments, we included diluent (heparin) in matrigel to assess base-
line alterations as a response to wound healing processes without exogenous growth factor stimulation. 
Capillaries were observed and recorded on a daily basis by intravital microscopy up to 7 days after 
matrigel sealing (Fig. 6B, and supplementary video 2). Vascular morphological parameters were quan-
tified in vessels where perfusion was observable. The vessels encompassed diameters ranging from 4 to 
20 μ m, thus capillaries and some small arterioles or venules. Capillary diameters significantly increased 
from day 1, 2, 4 and 7 compared to the baseline by about 2 μ m in average for both control and RictoriΔec  
capillary diameters (Fig.  6B). Importantly, the microvasculature of the panniculus carnosus responded 
similarly to wounding and matrigel sealing in control and RictoriΔec mice as we did not detect significant 
differences compared to controls at days 1, 2, 3, and 7 (Fig. 6B).
Endothelial-specific Rictor knockout limits increases in the capillary diameter of existing 
skin vasculature in response to high doses of FGF2. To assess remodeling in terms of individual 
increases in capillary diameters in response to strong angiogenic stimulation, we exposed the existing 
capillary bed to a high dose of FGF2 (1.5 μ g/ml). We focused on FGF2, since we found that Rictor dele-
tion specifically disabled FGF2- but not VEGFA-dependent angiogenesis in vitro as shown earlier in this 
manuscript. Furthermore, FGF2 also promotes maturation of larger vessels such as arterioles35. Intravital 
recordings through the dorsal skinfold chamber in control and RictoriΔec revealed that diameters increased 
at day 1 and day 2 after FGF2 exposure (Fig. 6C, day 1 and 2). In both groups, diameters had increased for 
about 3.5 μ m and we found no statistical difference between groups after testing by Bonferroni multiple 
comparisons (Fig. 6C). At days 4 and 7, capillary diameters further significantly increased in the control 
group when comparing to diameters at day 1. In addition, tortuous and bulbous vascular structures devel-
oped, which were observed in capillaries and small draining arterioles and venules (Fig. 6C, day 4 and 7). 
In RictoriΔec mice, however, FGF2-induced capillary enlargement stopped and rather regressed after day 
2. Statistically, capillary diameters at days 4 were not different from those measured at day 1. Diameters 
measured on day 4 and 7 in RictoriΔec were significantly smaller compared to the control group on those 
days (Fig. 6C). We observed, that at the end of the recording the vascular bed in RictoriΔec mice under-
went a far more restrained and different mode of remodeling. Thin-connecting anastomoses emerged 
between capillaries and draining arterioles in RictoriΔec mice, and the orientation of capillaries remained 
largely parallel (Fig. 6C and D, day 7 and supplementary video 3 and 4). The dilated and tortuous cap-
illary structures that developed in control mice after longer (4 and 7 days) exposure to FGF2 are also 
found in vascularized tumors, which in addition exhibit hyperpermeability36. We assessed vessel leakage 
of the FGF2-stimulated skin vascular bed on day 7 by intravenously injecting fluorescently labeled ricinus 
communis agglutinin I (RCA I)37. Preliminary data could however not support an obvious decrease in 
permeability by endothelial Rictor deletion as plasma leakage points were present in capillary structures 
from both control and RictoriΔec mice to a similar extent (suppl. Fig. S8).
Taken together, loss of endothelial Rictor normalized vascular structure after 4 days of exposure to 
FGF2 and prevented the formation of a heterogeneous, irregular microvascular bed as seen in controls 
(Fig. 6D). This suggests that endothelial mTORC2 is central to the FGF2-mediated remodeling response 
that creates larger and heterogeneously sized capillaries and small arterioles in the existing skin capillary 
bed beyond day 4.
Endothelial-specific Rictor knockout strongly reduces FGF2-induced neovascularization in 
matrigel plugs and prevents local hemorrhage. As technical limitations disabled us to monitor 
sprouting angiogenesis in the dorsal skinfold chamber, we used the matrigel plug angiogenesis assay to 
assess whether endothelial mTORC2 deficiency may alter de novo vascularization in adult mice in vivo 
in response to strong stimulation by FGF2 (1.5 μ g/ml). Concentrations of FGF2 in this range have been 
used previously to achieve maximal neovascularization after 7 days38 and to achieve macroscopically a 
hemorrhagic appearance (see also supplementary Fig. S9). Knockout of Rictor in the endothelium was 
induced during adolescence in RictoriΔec mice. At 7 days after implantation, blood-containing microves-
sels and signs of hemorrhage were macroscopically evident in FGF2-containing plugs from control mice. 
In contrast, FGF2-containing plugs from RictoriΔec mice displayed homogeneous, unobtrusive vasculari-
zation. An estimation of blood content by optical densitometry demonstrated a significant decrease after 
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Figure 6. Rictor knockout disables a sustained increase in skin capillary diameters and restricts extensive 
capillary remodeling in response to FGF2. (A) Stacked frames of representative videos of the capillary 
vasculature were recorded through the dorsal skinfold chamber by intravital fluorescence microscopy. Baseline 
capillary bed of the skin muscle was assessed in 10-week-old mice (6 weeks after knockout induction) by 
intravital microscopy through the unmodified dorsal skinfold chamber. Upper (20 × magnification) and 
lower micrographs (10×) display representative skin capillary beds of control (left) and RictoriΔec (right) 
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Rictor knockout in FGF2 containing plugs compared to control plugs (Fig. 7A, 1st row). FGF2-induced 
vessels protruded to about 800 μ m from the surface of the plug into the center in plugs from control 
mice, whereas microvessels protruded significantly less to only about 300 μ m in plugs from RictoriΔec 
mice. FGF2-induced microvessel protrusion into the plugs from RictoriΔec mice was not completely 
abolished as we calculated a significant difference to diluent containing plugs (Fig.  7A, 2nd row). The 
presence of leaked erythrocytes in the FGF2-containing plugs from control mice from one set of exper-
iments demonstrated local hemorrhage (Fig.  7B, left micrographs). In contrast, the microvasculature 
in FGF2-containing plugs from RictoriΔec mice was composed of homogenously small capillaries with 
no evidence of hemorrhage (Fig. 7B, right micrographs). Further micrographs showing hemorrhage in 
FGF2-containing plugs from 2 other sets of experiments are displayed in supplementary Fig. S10. During 
the 7 days of FGF2 administration, the matrigel plug was encapsulated by a thin layer of stromal tissue 
that also contained arterioles and venules. We found similar vessel densities in plugs from both exper-
imental groups (data not shown), whereas the luminal diameter was significantly smaller in vessels of 
the stromal capsule from RictoriΔec mice compared with control mice. No stromal vessels were found in 
diluent containing plugs from both groups (Fig. 7A, 3rd row). Angiogenesis occurring during postnatal 
development is usually connected with inflammation39. Macrophages were demonstrated to promote 
angiogenesis via FGFs and placental growth factor signaling39 or by the release of pro-angiogenic mol-
ecules39,40. We therefore investigated by CD68 immunestaining whether the stromal halo around the 
plugs may contain varying amounts of macrophages that could influence de novo angiogenesis in our 
experimental setting. However, we found no significant differences in the ratio between CD68+ cells to 
total cell nuclei in the peripheral stroma when comparing diluent and FGF2-containing plugs from both 
groups (Fig. 7A, last row). The total amount of CD68+ cells per field counted was also not significantly 
modulated, however, we noticed a trend towards higher macrophage count in stromal halos around 
FGF2-containing matrigel plugs from RictoriΔec mice (Fig. 7A, last row). To further investigate the pos-
sibility of a mild FGF2-dependent proinflammatory state after endothelial Rictor knockout we measured 
the mRNA levels of monocyte-attracting protein 1 (Mcp1) and vascular- and inducible cell adhesion 
molecules (Vcam1, Icam1) in MAEC. FGF2 increased Vcam1 mRNA after 24 hours similarly in both 
control and Rictor knockout MAEC. A slight and insignificant increase for Icam1 mRNA was observed. 
FGF2 robustly (ca. 6.6 fold) induced Mcp1 mRNA in control and Rictor knockout MAEC. Interestingly, 
Mcp1 mRNA remained at high levels (ca. 5.3 fold induction) after 24 h of FGF2 stimulation and was sig-
nificantly higher compared to controls (3.3 fold) at this timepoint (Fig. 7C). Thus, it is unlikely, that the 
strong reduction of FGF2-induced angiogenesis into matrigel plugs along with ‘normalized’ microvessel 
features by deletion of endothelial Rictor in vivo is caused by an altered inflammatory response.
Taken together, we observe a dense, heterogeneous neovasculature with several patches of hemorrhage 
indicating disrupted or leaky capillaries that formed after 7 days of FGF2-exposure in control mice. In 
contrast endothelial Rictor knockout strongly and significantly reduced neovessel ingrowth in response 
to FGF2 with capillaries remaining homogenously small, with no evidence of hemorrhagic spots.
Discussion
In this study we deleted Rictor in the endothelium to study the general requirement of endothelial 
mTORC2 during embryonic and adolescent development. Our analysis of embryonic development 
using constitutive and inducible VE-Cadherin-Cre-specific Rictor knockout confirmed that homozy-
gous Rictor deletion in endothelial cells is almost completely lethal and results in embryonic death 
around E12. Guertin et al. proposed that vascular defects may contribute to the lethality of whole-body 
Rictor knockout embryos on E10.514. Furthermore, Wang et al. demonstrated that the homozygous and 
mice. Capillary diameters from 10 control and RictoriΔec mice were quantified and pooled for statistical 
analysis (ncapillaries = 253/206, no differences between groups, 2-tailed T-test and Whisker plot, indicating 
median, 25% percentile and total range to the right). Color scheme applies for whole Fig. 6 and is displayed 
in upper right corner. B. Wounding response of the capillary bed. Skin muscle capillary structure from day 
1, 2, 4 and day 7 in control (left) and RictoriΔec mice (right) after wound sealing with heparin-containing 
matrigel (20 × magnification). Capillary diameters from 4 control and RictoriΔec mice were quantified and 
pooled for statistical analysis by 1-way ANOVA followed by Bonferroni multiple comparison (Scatter plot 
with medians on the below; number of capillaries (ncapillaries) are indicated below the X-axis, ****P < 0.0001). 
C. Heterogeneous capillary diameter increase in the FGF2-stimulated capillary bed. Skin muscle capillary 
structure from day 1, 2, 4 and day 7in control (left) and RictoriΔec mice (right) after wound sealing with 
FGF2 (1.5 μ g/ml; heparin-containing matrigel, 20 × magnification). Capillary diameters from 7 control and 
RictoriΔec mice were quantified and pooled for statistical analysis by 1-way ANOVA followed by Bonferroni 
multiple comparison (Scatter plot and medians below; number of capillaries are indicated below the X-axis, 
****P < 0.0001). D. Capillary remodeling in the FGF2-stimulated capillary bed. The line graph displays the 
normalized distribution of capillaries (nmax = 100) resolved in a 1-μ m range after FGF2 stimulation for 7 days 
and illustrates differences in remodeling between groups. Micrograph to the right shows 10x magnification of 
the vascular bed of control and RictoriΔec mice after 7 days of FGF2 exposure.
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Figure 7. Fibroblast growth factor 2(FGF2)-induced angiogenesis in matrigel plugs is reduced in RictoriΔec 
mice. (A) 1st row: Representative matrigel plugs containing heparin (diluent) or 1.5 μ g/ml FGF2 with heparin 
(FGF2) from 8-week-old male control (left) and RictoriΔec (right) mice removed 7 days after injection (scale 
bar = 1mm). Estimation of blood content by optical densitometry is shown on the right (nplugs = 4; **P < 0.01; 
1-way ANOVA with Bonferroni multiple comparison). (A) 2nd row: Paraffin sections from corresponding 
plugs immunostained for CD31 (brown) and hematoxylin (blue/nuclei). Representative micrographs show 
10 × magnification and display the depth of newly in grown microvessels from the surface towards the center 
of the matrigel plugs. Quantification to the right displays the significant reduction in the ingrowth (μ m) of 
neovessels into plugs from RictoriΔec mice compared to control mice (nplugs = 4/7; **P < 0.01, ****P < 0.0001; 
1-way ANOVA with Bonferroni multiple comparison). (A) 3rd row: Representative micrographs of peripheral 
stroma covering matrigel plugs. Identifiable inner microvessel diameters were measured (graph to the right; 
nplugs = 3; *P < 0.05;2-tailed T-test ). No vessels were found in peripheral stroma covering diluent-containing 
plugs. (A) 4th row: Representative micrographs of macrophage marker CD68-immunestainings of peripheral 
stroma and matrigel. Graphs to the right show ratio of CD68+/total cell nuclei in the stroma, and average of 
CD68 + cells per field counted in the stroma (nplugs = 4, no significant differences found after 1-way ANOVA/
Bonferroni multiple comparison). (B) Representative micrographs of one set of experiments displaying 
hematoxylin and eosin stained (H&E) matrigel areas showing local leakage and hemorrhagic areas in FGF2 
containing plugs from control mice compared to plugs from RictoriΔec mice (upper micrographs). Lower 
micrographs show higher magnification of CD31-stained matrigel areas. Arrowheads point to local spots 
of leaked erythrocytes in FGF2-containg control plugs. (C) Confluent and starved control and Rictor ko 
MAEC were stimulated for 1 and 24 hours with 25 ng/ml FGF2 or diluent. mRNA expression of monocyte 
attracting protein 1 (Mcp1), vascular and inducible cell adhesion molecules 1 (Vcam1, Icam1) was detected by 
quantitative real-time PCR (n = 3; *P < 0.05; 1-way ANOVA with Bonferroni multiple comparison test).
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Tie2-Cre-driven Rictor knockout is embryonically lethal17. Still, other than reductions in peripheral vas-
cularization, we did not detect gross abnormalities of the normal vascular plexi on E10.5. Surviving 
embryos around this time frame showed rather distinct and rare deficits in vascularization at E10.5. 
Surviving Rictor knockout embryos, however, consistently displayed growth retardation and a delayed 
ossification of the vertebrae, toes, and fingers. Delayed ossification may explain growth retardation but 
may not categorically explain embryonic lethality of RictoriΔec in the confined midgestational timeframe. 
Thus, other essential functions that are regulated by mTORC2 during this short period in midgestation 
are probable and may also account for lethality.
Many signaling pathways that are involved in early embryonic development are also recapitulated 
during tumorigenesis41. As we found that endothelial mTORC2 was required during a confined, midges-
tational timeframe but had no apparent influence on viability before midgestation (E8.5), beyond midg-
estation (E14.5), physiological vascular development, vascular maintenance and growth from adolescence 
into adulthood, we hypothesized that endothelial Rictor might promote only ‘aberrant’ endothelial phe-
notype modulation such as in tumor angiogenesis or during a transition to an invasive mesenchymal 
phenotype. Guertin et al. demonstrated that Rictor has no significant role by itself in maintaining the 
integrity of a normal prostate epithelium in vivo but requires Rictor to be transformed into an invasive, 
malignant phenotype by Pten deletion, which results in strong PI3K activation42. Similarly, Drosophila 
embryos lacking mTORC2 activity are viable and display only minor growth defects42,43. However, PTEN 
loss-induced tissue overgrowth in the Drosophila eye requires dTORC243.
We found that particularly FGF2 and not VEGFA depended on the mTORC2 signaling hub to estab-
lish a capillary-like endothelial network on matrigel substrate when we tested these PI3K-activating 
angiogenic molecules in vitro. We found that FGF2 elicited a strong and fast increase in the diameter of 
existing skin capillaries in the dorsal skinfold chamber after two days of stimulation in both control and 
RictoriΔec mice. Over a period of 7 days, FGF2 induced the progressive and extensive remodeling of vessel 
structures characterized by heterogeneous and larger diameter sizes that also included larger arterioles 
and a tortuous vascular bed in control mice. RictoriΔec mice however, could not maintain heterogeneous 
capillary size remodeling beyond day 2of FGF2 exposure and returned to ‘normalized’ vascular features 
with homogenously and smaller sized capillary diameters and parallel-oriented capillaries. Tortuous 
and dilated capillaries are also found in vascularized tumors. Tumor blood vessels furthermore display 
hyperpermeability, and do not mature into functional vasculature1,2. However, we could not detect fewer 
leakage points in FGF2-stimulated skin capillaries RictoriΔec in preliminary investigations.
However, the supply of FGF2 to the skin muscle over a period of seven days was limited by the vol-
ume of the matrigel carrier (16 μ l) and may not have provided saturated FGF2-stimulation at all times. 
We therefore continued our investigations using the matrigel plug assay carrying pathologically high 
doses of FGF2 in a volume of 200 μ l to induce aberrant, leaky and tumor-like angiogenesis as reported 
before38. Indeed, we observed a dense, heterogeneous neovasculature with several patches of hemorrhage 
that formed after 7 days in control mice. Endothelial Rictor knockout strongly and significantly reduced 
FGF2-mediated neovessel ingrowth, and capillaries remained homogenously small with no microscopic 
signs of leakage. Our study thus demonstrates that endothelial mTORC2 acted as a central signaling hub 
for FGF2-induced persistent capillary diameter increases and remodeling into heterogeneous capillary 
structures and formation of a leaky, tumor-like neovasculature in the adult mouse.
FGF2, which is not secreted through vesicular pathways, can be exported from cells with unique 
extrusion pathways or large amounts can be released upon cell death44,38. FGF2 has been selectively 
determined as a crucial tumorigenic cytokine in prostate cancers in which both FGF2 and FGF2 recep-
tor subtypes are co-expressed45,46. In addition many other tumor types express FGF2/FGFRs at high 
levels38,47–51. On the other hand, fibroblast growth factors are involved in the formation of skeletal ele-
ments within the developing limb52–54. Several FGFs are expressed in developing endochondral bone. 
FGF2 was the first FGF ligand to be isolated from growth plate chondrocytes52. FGF2 expression has 
also been observed in periosteal cells and in osteoblasts51,55. Targeted deletion of FGF2 causes a relatively 
subtle defect in osteoblastogenesis, leading to decreased bone growth and bone density51,56.
Mechanistically, we could not substantiate, that the extensive mTORC2-dependent FGF-induced 
angiogenic responses were executed by coupling to the VEGFA/VEGFR system, which also determines 
endothelial tip-/stalk phenotypes31. Also, FGF2-induced endothelial proliferation and migration were 
unaltered after Rictor knockout. In contrast, we found VEGFA-induced proliferation to be significantly 
decreased by Rictor knockout as previously reported17. Endothelial Rictor knockout resulted in dephos-
phorylation of typical mTORC2 downstream targets and blunted FGF2-induced phosphorylation of 
PSer473AKT and PSer657PKCα 25. The results by Wang et al. suggest that mTORC2 is a critical signaling 
node required for VEGF-mediated angiogenesis through the regulation of AKT and PKCα in vascular 
endothelial cells17. AKT is activated by most endothelial growth factors (FGF2, VEGF, and angiopoietin) 
and orchestrates a number of signaling pathways that are involved in angiogenesis1,57,58. For example, 
FGF2-induced capillary morphogenesis via FGFR1 is impaired in murine brain capillary endothelial cells 
expressing an inactive AKT57,59. FGF2-induced angiogenesis may partially depend on AKT signaling, 
potentially via transcription factors FoxO1/FoxO3a27,60.
Interestingly we found that quiescent and starved MAEC expressed low levels of RICTOR in con-
trol cells. High doses of FGF2 however induced RICTOR protein in correlation with high PSer473AKT. 
Comparable findings were reported during the epithelial to mesenchymal transition (EMT). Transforming 
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growth factor (TGF-β ), a strong inducer of EMT, increased RICTOR protein and thereby formation 
of mTORC2 in mouse mammary gland epithelial cells13. Without Rictor, the epithelial cells arrested 
in an intermediate stage between epithelial and mesenchymal differentiation, without the motile and 
invasive behavior of cells after EMT13. Interestingly, TGFβ -1 treatment also induces an interaction 
between RICTOR and integrin-linked kinase (ILK) and promotes ILK-dependent EMT. This complex 
was detected in cancer but not in normal cell types61 and overlaps with mTORC2 in the function as 
PSer473AKT kinase62. Thus, Rictor could promote EMT by forming different complexes.
In parallel to EMT, endothelial to mesenchymal transition (EndoMT) can be induced by transforming 
growth factor (TGF-β )63. EndoMT is a newly recognized type of cellular transdifferentiation that partic-
ipates in development, but also in pathological conditions such as cancer and fibrosis63–65. New studies 
have shown that EndoMT represents a dedifferentiation of endothelial cells to a stem cell phenotype, 
which can redifferentiate into bone or cartilage cells63,64,66. Thus, hypothetically, endothelial Rictor may be 
required during midgestation to promote the transition of endothelial cells to a mesenchymal, osteogenic 
phenotyope to promote FGF2-directed ossification of limbs and vertebrae. During further development 
through normal adolescence where most vasculature is quiescent, with only 0.01% of endothelial cells 
undergoing division67, endothelial Rictor knockout may represent the characteristics of an unchallenged 
quiescent endothelial monolayer with low RICTOR expression and AKT activity. Recent studies sug-
gest, during angiogenic sprouting, endothelial cells express many of EndoMT-driving genes and break 
down basement membrane. However, they retain intercellular junctions and migrate as a connected train 
of cells65. This process has been termed a partial EndoMT65. The permanently activated phenotype of 
tumor vasculature may well reflect the chronic activation of the EndoMT process, driven by persistent 
angiogenic cascades, leading to excessive sprouting and a failure to settle back into the mature, sta-
ble phenotype65. Thus, hypothetically, endothelial mTORC2, assembled through increased expression of 
FGF2-induced RICTOR may promote neovascularization by a sustained partial EndoMT.
In conclusion, we demonstrated that endothelial Rictor is crucial for progression through midgesta-
tion and for timely ossification. In adolescence, the FGF2-RICTOR axis promoted sustained, extensive 
and aberrant neovascularization. During adolescent vascular quiescence or moderate capillary remode-
ling, however, endothelial mTORC2/RICTOR was not required. Further studies are needed to uncover 
the exact molecular nature that may enable endothelial mTORC2/RICTOR to promote both embryonic 
development and extensive and aberrant FGF2-dependent angiogenesis in the adult.
Materials and Methods
Animal procedures. Mice with floxed Rictor exons68,69 were crossed with mice that express tamoxifen 
inducible Cre-ERT2 under the control of the endothelium-specific VE-cadherin promoter (VECad-Cre-
ERT2)22 (kind gift of Dr. Iruela-Arispe, Department of Molecular, Cell & Developmental Biology, UCLA, 
USA) both on a congenic C57Bl/6J background. Offspring were genotyped for Cre-recombinase, Rictorfloxed 
and Rictorwt alleles using qPCR. Briefly, DNA was isolated from ear biopsies and amplified by qPCR with 
the following primer pairs (5′ -3′ ): Forward: GCG GTC TGG CAG TAA AAA CTA TC; Reverse: GTG 
AAA CAG CAT TGC TGT CAC TT. The mice were bred, housed and handled according to the local 
animal ethics committee. All procedures with mice were approved by the Veterinary Office of the Canton 
of Zürich, Switzerland under licenses 77/2009 and 179/2012. We confirm that all procedures with mice 
were performed according the legislation of the Swiss Protection of Animals Act for vertebrates within 
the strict guidelines of the licenses 77/2009 and 179/2012 and additional local directives of the animal 
housing facilities.
Whole mount embryo staining. Embryos were stained with an antibody against endomucin accord-
ing to Vieira et al.70. In brief, embryos were fixed for two hours on ice with PBS containing 4% PFA. 
After three washing steps with PBS containing 0.1% Triton X-100 and blocking of unspecific binding 
sites by incubation with PBS containing 10% FCS and 0.1% Triton X-100 for 30 minutes at room tem-
perature, embryos were incubated with rat monoclonal antibody against endomucin (1:100, Santa Cruz 
Biotechnology) dissolved in PBS over night at 4 °C followed by five washing steps with PBS at room tem-
perature. After incubation with secondary antibody anti-rat Alexa Fluor-555 (1:200, Molecular Probes) 
over night at 4 °C and three further washing steps with PBS, embryos were mounted and analyzed by 
laser scanning confocal microscopy (SP5; Leica, Wetzlar, Germany). Staining of whole embryos for LacZ 
was as described previously71.
Alizarin Red and Alcian Blue stainings. For skeletal staining, embryos were fixed in 95% ethanol 
for more than four days, after removal of fat and connective tissue, incubated in acetone for one day 
and stained with 0.15% alcian blue 8GS (Sigma-Aldrich)/0.05% alicarin red S (Sigma-Aldrich)/5% acetic 
acid in 70% ethanol at 37 °C for two days. After bleaching in 1% KOH for 12 to 48 hours embryos were 
destained with graded washes of glycerin (20% glycerin in 1% KOH, 50% glycerin in 1% KOH and 80% 
KOH in 1% glycerin). Embryos were stored in 100% glycerin.
Histological analysis. Embryos and dissected organs from adult mice were fixed in 4% PFA in PBS, 
transferred to ethanol and embedded in paraffin. Longitudinally-sectioned paraffin-embedded embryos 
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and organs were stained with hematoxylin and eosin. For CD 31 staining paraffin sections were stained 
as described previously72. Sections from dorsal chambers were de-paraffinized and rehydrated in xylene 
and isopropanol and antigens retrieved by boiling in Na3 citrate. Rabbit polyclonal anti-mouse Estrogen 
Receptor α antibody (Millipore) was used for detection and visualized by secondary goat anti-rabbit 
Alexa-Fluor 555 (Invitrogen) using microscopes and cameras from Zeiss and Olympus.
Determination of Rictor mRNA expression levels in endothelial cells from thoracic aorta. 
Rictor deletion was induced in VECad-CreERT2+; Rictorfloxed/floxed mice at an age of four weeks with five 
consecutive intraperitoneal tamoxifen (Tx) injections according to the protocol of Monvoisin et al.22. 
(2 mg Tx/ml dissolved in corn oil at a concentration of 80 mg/kg bodyweight, T5648, Sigma-Aldrich). 
Littermate control mice were injected with corn oil alone. This injection protocol was used for all exper-
iments in this study.
Aortae were excised from 6 month old Tx-injected (RictoriΔec) and control mice (Ctrl), cleaned from 
adhering tissue and opened longitudinally. Endothelial cells were carefully scraped directly in RLT buffer 
(Qiagen) and RNA was extracted using the RNAeasy micro kit (Qiagen) according to the recommendations 
of the manufacturer. Equal amounts of RNA were transcribed to cDNA by WT (Whole Transcript)-Ovation™ 
Pico RNA Amplification System (NuGEN). Quantitative real-time PCR was performed using a SYBR 
green-based standard protocol. Primer list is shown in section ‘Real-time quantitative reverse transcription 
polymerase chain reaction’. Specificity of the primers was tested by melt curve and agarose gel analysis and 
sequencing. Relative expression levels were calculated using the comparative Δ Ct method73.
Isolation of endothelial cells. Mouse aortic endothelial cells (MAECs) were isolated from aortae 
of 8–10 weeks old Rictor floxed male mice as described earlier74,75. Briefly, fibrin gels were prepared by 
mixing 3 mg/ml of fibrinogen with serum-free DMEM complemented with non-essential amino acids, 
Sodium Pyruvate, Pen-Strep and thrombin on ice. 24-well plates were coated with the prepared fibrin gel 
allowed to polymerize at 37 °C. The excised aorta was cleaned, cut in small rings and placed on top of the 
gel and overlaid by fibrin gel. After gel had polymerized pre-warmed growth media (serum-free DMEM 
that contained 10% FCS, 200 μ g/ml of ECGS, 10 ng/ml FGF2 and 0.1 IE/ml of heparin) was loaded to 
the wells. To protect the fibrin gel from degradation, 300 μ g/ml of ε -amino caproic acid (Sigma A-7824) 
diluted in PBS was added to all wells every other day. After 10 days of culturing, capillary-like sprouts 
were observed under the microscope. The outgrown cells were harvested by pipetting up and down the 
fibrin gel. The gel-cell mixture was transferred to a six-well plate which had previously been coated with 
0.1% gelatin gold, and 1 ml/well of growth media w/o heparin was added. The next day, cells were washed 
once with warm PBS and new EC growth media was added. Confluent cells were split 1:2 by trypsin-
ization using TrypLETM-Express and characterized with endothelial cell specific immuno-fluorescent 
marker von Willebrand Factor (VWF, LabForce AG).
Cell culture and treatments. For all experiments using MAECs, cell culture dishes were coated with 
0.1% gelatin gold (Carl Roth GmbH 4274.1) for 20 minutes at 37 °C. MAECs were maintained in DMEM 
(Biochrom FG435), complemented with 10% or 1% (complete or starvation medium) FCS (Biochrom 
S0615), 1% sodium pyruvate (GIBCO 15140), 1% non-essential amino acids (GIBCO 11140) and 1% 
penicillin-streptomycin (GIBCO 15140). Stimulation with growth factors always included addition of 
heparin at a fixed ratio (1 IU heparin per 1.5 μ g/ml FGF).
Generation of Rictor ko cells. Rictor knockout was induced by adenoviral transfection of Cre- 
Recombinase on Rictor floxed MAEC. 2.5 × 105 Rictor floxed MAECs were seeded on a 6 cm culture 
dish. The next day, the media was removed and a virus (100 MOI) that contained either Ade-CRE-GFP 
(Vector Biolabs 1045) or Ade-CMV-GFP (Vector Biolabs 1060) was added in 1 ml of growth media to the 
cells. After 7 hours, the media was removed, replaced by 4 ml of normal growth media, and incubated 
at 37 °C. Endothelial cells expressed GFP the following day. Down-regulation of Rictor and disruption 
of mTORC2 signaling was assessed by using qRT-PCR and western blotting 3 days after transfection 
(see also Fig.  4 lower left panel). Steps that involved handling viruses or virus-transfected cells were 
performed in a level-2 biosafety hood (Skan VSB 90) in a certified cell culture laboratory.
Endothelial network-formation assay in vitro. Angiogenesis in vitro was assessed on the basis 
of a tube formation assay. Twenty-four-well culture plates (Costar; Corning) were coated with growth 
factor-reduced matrigel (BD Biosciences) in a total volume of 150 μ L and allowed to solidify for 30 min 
at 37 °C. Tracking dye green (CytoPainter, abcam ab138891) was dissolved in 100 μ l DMSO (= stock 
solution (1000× )). 20 μ l of stock solution was mixed with 5 ml assay buffer. Cells were washed once with 
PBS, and 5 ml tracking dye green working solution added to the cells and incubated for 45 min at 37 °C 
in an CO2 incubator. Labeled MAEC were trypsinized and resuspended to a concentration of 105/mL 
in DMEM/1% FCS. 500 μ l of the cell suspension were added into each well and complemented with dil-
uent (heparin) and growth factors (FGF2; VEGFA 25ng/ml with heparin). Then the cells were incubated 
at 37 °C for eighteen hours. The appearance of endothelial network was observed under an inverted 
microscope by fluorescence (FITC; Ex/Em = 490/520 nm) with a 4x objective (IX70, Olympus) and 
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photographed. Number of master segments were quantified automatically using the Macro ‘Angiogenesis 
Analyzer’ by Gilles Carpentier (Gilles Carpentier. Contribution: Angiogenesis Analyzer, ImageJ News, 5 
October 2012) for NIH Image J 1.47v Program.
Immunoblotting. To extract protein, cells were washed twice with ice cold PBS and then harvested 
by scraping with a cell scraper (BD Falcon 353089) into 1 ml of ice cold PBS. The cell suspension was 
collected with a 1 ml pipette, transferred to a 2 ml Eppendorf tube, and then centrifuged for 5 minutes at 
14,000 rpm at 4 °C. The pellet was resuspended in RIPA buffer (50 mM TrisHCl (pH7.4), 150 mM NaCl, 
1 mM EDTA(pH8), 1% Triton X-100, 0.1% SDS, 0.25% Na-deoxycholate) that contained a complete 
mini protease inhibitor (Roche 11836153001) and a phosphatase inhibitor cocktail 2 (Sigma P5726). The 
sample was centrifuged for 15 minutes at 14,000 rpm at 4 °C. The resulting supernatant was transferred 
to a new 1.5-ml Eppendorf tube and the protein concentration measured by using a BCA protein assay 
kit (Thermo scientific 23223). Equal amounts of protein were loaded onto a 8% acrylamide-SDS gel. 
Separated proteins were transferred to a nitrocellulose membrane (Whatman BA85) using a semidry 
blotting procedure, blocked for 1 hour at room temperature (RT) in 5% Bovine Serum Albumine (BSA, 
Sigma-Aldrich A7906) in Tris buffered saline complemented with 0.1% Tween (TBS-T). Membranes were 
washed once with TBS-T and incubated overnight at 4 °C with one of the following primary antibod-
ies against Rictor (#2140), Phospho-AKT (Ser473) (#9271), Phospho-AKT(Thr308) (#9275), AKT(#9272), 
PKCα , Phospho-PKCα (Ser657)(Santa Cruz Biotechnology, #12356), Phospho-ERK1/2 (Thr202/Tyr204) 
(#9101), ERK1/2 (#9102), Phospho-S6K1 (Thr389) (#9205), S6K1 (#9202) and ) and Phospho-S6 RP 
(Ser235/236) (#4858), all from Cell signaling (BioConcept, Switzerland) in a dilution of usually 1:1000. 
Mouse anti β -Actin 1:10,000 (Sigma A-5441) was used to control equal loading. The next day, the mem-
brane was washed three times in TBS-0.1% tween and incubated with a secondary antibody goat anti 
rabbit HRP 1:5,000 (Cell Signaling 7074) or anti mouse HRP 1:50,000 (Cell Signaling 7076) for 1 hour 
at room temperature (RT). After another wash step, a chemiluminescent substrate that is used for the 
detection of HRP (Thermo Scientific 34080) was applied to the membrane, and then the membrane was 
incubated for 1 minute. The signal was detected with a CL-XPosure film (Thermo Scientific 34088), and 
the resulting bands were quantified by using ImageJ (Wayne Rasband, NIH, MD, USA).
Real-time quantitative reverse transcription polymerase chain reaction. qRT-PCR was per-
formed as described previously76,77. RNA was isolated using the RNAeasy Mini kit (Qiagen, Hilden, 
Germany), followed by an on column DNA digestion (Qiagen, Hilden, Germany). cDNA was transcribed 
from total RNA using Omniscript RT kit (Qiagen, Hilden, Germany) and random primers (Roche, Basel, 
Switzerland). To control for DNA contamination in the qRT-PCR, for each sample a control reaction 
missing reverse transcriptase was additionally amplified. Primers used are listed (5′ → 3′ ) below (Table 
1). Primers were tested by cDNA dilution series to obtain optimal reaction conditions. qRT-PCR was 
performed using an iCycler iQ Real Time PCR Detection System (Biorad, Reinach, Switzerland) and 
iQ™ SYBR® Green Supermix (Biorad). Melting curve of each representative reaction was analyzed. The 
qRT-PCR was quantified using the formula: 2−ΔCT = CT gene of interest – CT Tubulin73.
Proliferation assay. 4500 cells with 100 μ l of growth media were seeded in a 96-well plate in 10 rep-
licates. After serum-starvation (0.5% FCS) for 26 hours, cells were stimulated with 5–25 ng/ml of FGF2 
Gene Forward Reverse
Rictor TGC GAT ATT GGC CAT AGT GA ACC CGG CTG CTC TTA CTT CT,
Gapdh AAA TGG TGA AGG TCG GTG TG GTT GAA TTT GCC GTG AGT GG,
Tubulin (Tuba1a) TCA CTG TGC CTG AAC TTA CC GGA ACA TAG CCG TAA ACT GC
β-actin (Acta1) CGT GCG TGA CAT CAA AGA GA CCC AAG AAG GAA GGC TGG A
mFlt1 GCT TCT GGA GGA CGT CAA CA TCC CGA TAC AGG GCT TCA GA
sFlt1 CTC CTC TGT CCA CCC AGG TA CTG CAC TTT TGC CGT CAG TC
VegfA TTC GTC CAA CTT CTG GGC TC CGA GCT AGC ACT TCT CCC AG
KDR GGA AGG CCC ATT GAG TCC AA GTT GGT GAG GAT GAC CGT GT
FgfR1 CGT AGG CCT GTA GCT CCC TA TGA ACT TCA CCG TCT TGG CA
Pkcα GGA ATG AGT CCT TCA CGT TCA AA TTA GCT CTG AGA CAC CAA AGG
MCP1 (Ccl2) CAG GTC CCT GTC ATG CTT CT GTG GGG CGT TAA CTG CAT CT
Vcam1 GGC TGC GAG TCA CCA TTG GCA CAG GTA AGA GTG TTC ATT C
Icam1 GAC GCA GAG GAC CTT AAC AG GAC GCC GCT CAG AAG AAC
Table 1. List of primer sequences (5′ → 3′ ).
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or VEGFA, 10% FCS or 100μ g/ml of insulin. After 72 hours, 10 μ l of WST-1 solution (Roche Molecular 
Diagnostics) was added for 2 hours. Absorption was measured (A450nm-A690nm) by using a Spectramax 
M2 reader (Molecular Devices).
Migration assay (wound healing). MAECs were grown to confluency, starved (0.5% FCS) for 24 
hours. A straight scratch using a 200 μ l sterile tip was applied to the confluent monolayer (Star Lab, 
#S1120-8810). The monolayer was stimulated with diluent and FGF2 (25 ng/ml). The migration of the 
cells was photographed with an inverted microscope (Olympus IX71) at different time points (0, 1, 3, 
6 and 9 hours after the stimulation) and measured with the software T-Scratch® (Tobias Gebäck and 
Martin Schulz, ETH Zürich, 2008).
Mouse dorsal skin fold chamber and matrigel sealing. To study the capillary remodeling and 
angiogenesis in vivo we used the dorsal skin fold chamber as described previously33 with a novel mod-
ification in order to deliver growth factors via matrigel to the tissue. For chamber implantation, two 
symmetrical titanium frames were mounted on the dorsal skin fold of the animal. One skin layer and the 
underlying fat were then completely removed in a circular area of 15 mm in diameter, and the remaining 
layers (consisting of striated skin muscle, subcutaneous tissue and skin) were covered with NaCl2 0.9% 
and a glass cover slip incorporated into one of the titanium frames33. The animals were allowed to recover 
for two days. Skin was detached from the underlying muscle and removed in a circular area of 7 mm in 
diameter from the back of the chamber. Growth-factor reduced matrigel was mixed with FGF2 (1.5 μ g/
ml) and Heparin (5 IU units) or Heparin alone. The defect on the back of the chamber was sealed with 
16μ l of the matrigel mixtures, allowed to polymerize, and covered with a glass cover slip.
Intravital microscopy. Repetitive intravital microscopic analyses of skin microvasculature were car-
ried out daily over a time period of 7 days. Microscopic images were taken at 8 different areas within 
the center and the periphery of the wound. After injection of 0.2 ml FITC-labeled dextran (2%; MW 
70000, Sigma-Aldrich, Munich, Germany) the microcirculation was visualized by intravital fluorescence 
microscopy. (Leica DM/LM; Leica Microsystems, Wetzlar, Germany). Microscopic images were captured 
by a CCD television camera (Kappa Messtechnik, Gleichen, Germany) and recorded on video (50Hz; 
Panasonic AG-7350-SVHS, Tokyo, Japan) for subsequent off-line analysis. Using ×10 (N-Plan ×10/0.25 
LD, Leica), ×20 (HCX Apo ×20/0.50W, Leica) objectives blood flow was monitored in capillaries of 
the superficial and deep dermal plexus of the skin muscle. The epi-illumination setup included a mer-
cury lamp with a blue filter (450–490 nm/> 520 nm excitation/emission wavelength) and a green filter 
(530–560 nm/> 580 nm).
Matrigel plug assay. The matrigel plug assay was performed as previously described78. In brief, 
8-week-old C57BL/6 mice were injected subcutaneously with 0.2 ml of matrigel containing 1.5 μ g/ml 
bFGF with 1 μ l (5 IU) Heparin. The injected matrigel rapidly formed a single, solid gel plug. After 7 
days, mice were euthanized, the skin was pulled back to expose the matrigel plug. The matrigel plug 
was removed, photographed and fixed in formalin and paraffin embedded. Hemoglobin content was 
estimated by measuring mean pixel densities from five random 200 × 200 pixel areas from the magenta 
channel in CMKY converted images from each plug by the NIH ImageJ program.
The Matrigel plugs were removed and fixed in 4% buffered formalin. After 48 h fixation, the plugs 
were trimmed, dehydrated in graded alcohol and routinely paraffin wax embedded. Sections (3–5 μ m 
thick) were prepared, mounted on glass slides, de-paraffinized in xylene, rehydrated through graded 
alcohols and stained with hematoxylin and eosin (HE) for the histological examination. For analysis of 
immunestainings, sections of one plug were photographed in three different areas (350 × 350 pixels), 
quantified and averaged. The n number refers to the mean of 3 areas of one plug. E.g. for microvessel 
invasion n = 4/7 refers to 4 groups of 3 averaged areas from control plugs compared to 7 groups of 3 
averaged areas from 7 Rictor ko plugs. Immunohistology for CD31 antigen was employed to highlight 
endothelial cells. Anti-CD-31 immunohistochemical staining was performed according to manufacturer’s 
protocol (Lifespan Biosciences). Slides were photographed using a brightfield microscope (Zeiss Axioskop 
2, Germany). Immunohistology for the CD68 antigen was employed to highlight cells of the mono-
cyte/macrophage lineage79. Briefly, sections were deparaffinized in xylene (2 × 5 min) and rehydrated 
in decreasing concentrations of ethanol (2 × 3 min washes in 100% ethanol, followed by 1 × 3 min wash 
in 96% ethanol). Sections were washed twice with Tris-buffered saline (TBS, 0.1 M Tris–HCl with 0.9% 
NaCl, pH 7.4) and incubated for 1 h at 37 °C with the primary antisera (1:100, ab125212, Clone KP1, 
Abcam, Cambridge, United Kingdom), after heat pre-treatment in citrate acid (0.01M, pH 9.0) in a 97 °C 
water bath for 20 min. An anti-rabbit IgG DAB detection system was subsequently applied according to 
the manufacturer’s protocols (Discovery OmniMap anti-Rb HRP, Roche, Basel, Switzerland). Sections 
were then washed 3 × in TBS and 1 × in distilled water and counterstained for 1 min with hematoxylin, 
followed by rinsing for 5 min in tap water and dehydration in ascending alcohols, clearing in xylene, 
coverslipping and mounting. Sections of murine immune system organs were used as positive control. 
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All slides were scanned using digital slide scanner NanoZoomer-XR C12000 (Hamamatsu, Japan) and 
images were taken using NDP.view2 viewing software (Hamamatsu).
Statistical analysis. Statistical tests were performed by GraphPad Prism 5.04 software (San Diego, 
CA, USA). On a general basis, two-way analysis of variance (ANOVA), followed by a Bonferroni-post 
test comparing all pairings was calculated whereby a P value of less than 0.05 was considered as statis-
tically significant. For the comparison of two groups, the unpaired t-test was used. Datapoints in graphs 
represent average values ± standard error of the mean unless otherwise stated.
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